1	Two	two	_	_	_	_	_	_	_
2	distinct	distinct	_	_	_	_	_	_	_
3	pathways	pathway	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	interleukin-5	interleukin-5	_	_	_	_	_	_	_
6	synthesis	synthesis	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	allergen-specific	allergen-specific	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	T-cell	t-cell	_	_	_	_	_	_	_
11	clones	clone	_	_	_	_	_	_	_
12	are	be	_	_	_	_	_	_	_
13	suppressed	suppress	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Glucocorticoids	Glucocorticoid	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	GC	GC	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	have	have	_	_	_	_	_	_	_
6	long	long	_	_	_	_	_	_	_
7	been	be	_	_	_	_	_	_	_
8	used	use	_	_	_	_	_	_	_
9	as	as	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	most	most	_	_	_	_	_	_	_
12	effective	effective	_	_	_	_	_	_	_
13	agents	agent	_	_	_	_	_	_	_
14	for	for	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	treatment	treatment	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	allergic	allergic	_	_	_	_	_	_	_
19	diseases	disease	_	_	_	_	_	_	_
20	accompanied	accompany	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	eosinophilia	eosinophilia	_	_	_	_	_	_	_
23	such	such	_	_	_	_	_	_	_
24	as	as	_	_	_	_	_	_	_
25	chronic	chronic	_	_	_	_	_	_	_
26	asthma	asthma	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	atopic	atopic	_	_	_	_	_	_	_
29	dermatitis	dermatitis	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	development	development	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	chronic	chronic	_	_	_	_	_	_	_
5	eosinophilic	eosinophilic	_	_	_	_	_	_	_
6	inflammation	inflammation	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	dependent	dependent	_	_	_	_	_	_	_
9	on	on	_	_	_	_	_	_	_
10	interleukin-5	interleukin-5	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	IL-5	IL-5	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	selective	selective	_	_	_	_	_	_	_
17	eosinophil-activating	eosinophil-activating	_	_	_	_	_	_	_
18	factor	factor	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	produced	produce	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	helper	helper	_	_	_	_	_	_	_
23	T	t	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	delineate	delineate	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	regulatory	regulatory	_	_	_	_	_	_	_
5	mechanisms	mechanism	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	human	human	_	_	_	_	_	_	_
8	IL-5	il-5	_	_	_	_	_	_	_
9	synthesis	synthesis	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	we	we	_	_	_	_	_	_	_
12	established	establish	_	_	_	_	_	_	_
13	allergen-specific	allergen-specific	_	_	_	_	_	_	_
14	CD4+	cd4+	_	_	_	_	_	_	_
15	T-cell	t-cell	_	_	_	_	_	_	_
16	clones	clone	_	_	_	_	_	_	_
17	from	from	_	_	_	_	_	_	_
18	asthmatic	asthmatic	_	_	_	_	_	_	_
19	patients	patient	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	GC	GC	_	_	_	_	_	_	_
2	efficiently	efficiently	_	_	_	_	_	_	_
3	suppressed	suppress	_	_	_	_	_	_	_
4	IL-5	il-5	_	_	_	_	_	_	_
5	synthesis	synthesis	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	T-cell	t-cell	_	_	_	_	_	_	_
8	clones	clone	_	_	_	_	_	_	_
9	activated	activate	_	_	_	_	_	_	_
10	via	via	_	_	_	_	_	_	_
11	either	either	_	_	_	_	_	_	_
12	T-cell	t-cell	_	_	_	_	_	_	_
13	receptor	receptor	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	TCR	TCR	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	or	or	_	_	_	_	_	_	_
18	IL-2	il-2	_	_	_	_	_	_	_
19	receptor	receptor	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	IL-2R	IL-2R	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Induction	Induction	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	IL-5	IL-5	_	_	_	_	_	_	_
4	mRNA	mRNA	_	_	_	_	_	_	_
5	upon	upon	_	_	_	_	_	_	_
6	TCR	TCR	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	IL-2R	IL-2R	_	_	_	_	_	_	_
9	stimulation	stimulation	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	totally	totally	_	_	_	_	_	_	_
12	inhibited	inhibit	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	dexamethasone	dexamethasone	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Human	human	_	_	_	_	_	_	_
2	IL-5	IL-5	_	_	_	_	_	_	_
3	promoter/enhancer-luciferase	promoter/enhancer-luciferase	_	_	_	_	_	_	_
4	gene	gene	_	_	_	_	_	_	_
5	construct	construct	_	_	_	_	_	_	_
6	transfected	transfecte	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	T-cell	t-cell	_	_	_	_	_	_	_
9	clones	clone	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	transcribed	transcribe	_	_	_	_	_	_	_
12	on	on	_	_	_	_	_	_	_
13	either	either	_	_	_	_	_	_	_
14	TCR	TCR	_	_	_	_	_	_	_
15	or	or	_	_	_	_	_	_	_
16	IL-2R	IL-2R	_	_	_	_	_	_	_
17	stimulation	stimulation	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	was	be	_	_	_	_	_	_	_
20	clearly	clearly	_	_	_	_	_	_	_
21	downregulated	downregulate	_	_	_	_	_	_	_
22	by	by	_	_	_	_	_	_	_
23	dexamethasone	dexamethasone	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	indicating	indicate	_	_	_	_	_	_	_
26	that	that	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	approximately	approximately	_	_	_	_	_	_	_
29	500-bp	500-bp	_	_	_	_	_	_	_
30	human	human	_	_	_	_	_	_	_
31	IL-5	il-5	_	_	_	_	_	_	_
32	gene	gene	_	_	_	_	_	_	_
33	segment	segment	_	_	_	_	_	_	_
34	located	locate	_	_	_	_	_	_	_
35	5	5	_	_	_	_	_	_	_
36	â€™	'	_	_	_	_	_	_	_
37	upstream	upstream	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	the	the	_	_	_	_	_	_	_
40	coding	cod	_	_	_	_	_	_	_
41	region	region	_	_	_	_	_	_	_
42	contains	contain	_	_	_	_	_	_	_
43	activation-inducible	activation-inducible	_	_	_	_	_	_	_
44	enhancer	enhancer	_	_	_	_	_	_	_
45	elements	element	_	_	_	_	_	_	_
46	responsible	responsible	_	_	_	_	_	_	_
47	for	for	_	_	_	_	_	_	_
48	the	the	_	_	_	_	_	_	_
49	regulation	regulation	_	_	_	_	_	_	_
50	by	by	_	_	_	_	_	_	_
51	GC	GC	_	_	_	_	_	_	_
52	.	.	_	_	_	_	_	_	_

1	Electrophoretic	electrophoretic	_	_	_	_	_	_	_
2	mobility	mobility	_	_	_	_	_	_	_
3	shift	shift	_	_	_	_	_	_	_
4	assay	assay	_	_	_	_	_	_	_
5	analysis	analysis	_	_	_	_	_	_	_
6	suggested	suggest	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	AP-1	ap-1	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	are	be	_	_	_	_	_	_	_
12	among	among	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	possible	possible	_	_	_	_	_	_	_
15	targets	target	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	GC	GC	_	_	_	_	_	_	_
18	actions	action	_	_	_	_	_	_	_
19	on	on	_	_	_	_	_	_	_
20	TCR-stimulated	tcr-stimulated	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	NF-AT	NF-AT	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
4	were	be	_	_	_	_	_	_	_
5	not	not	_	_	_	_	_	_	_
6	significantly	significantly	_	_	_	_	_	_	_
7	induced	induce	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	IL-2	il-2	_	_	_	_	_	_	_
10	stimulation	stimulation	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	showing	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	GC	GC	_	_	_	_	_	_	_
6	suppressed	suppress	_	_	_	_	_	_	_
7	IL-5	il-5	_	_	_	_	_	_	_
8	production	production	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	human	human	_	_	_	_	_	_	_
11	CD4+	cd4+	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	activated	activate	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	two	two	_	_	_	_	_	_	_
17	distinct	distinct	_	_	_	_	_	_	_
18	stimuli	stimulus	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	TCR	TCR	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	IL-2R	IL-2R	_	_	_	_	_	_	_
23	stimulation	stimulation	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	underscore	underscore	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	efficacy	efficacy	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	GC	GC	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	treatment	treatment	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	allergic	allergic	_	_	_	_	_	_	_
35	diseases	disease	_	_	_	_	_	_	_
36	via	via	_	_	_	_	_	_	_
37	suppression	suppression	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	T-cell	T-cell	_	_	_	_	_	_	_
40	IL-5	IL-5	_	_	_	_	_	_	_
41	synthesis	synthesis	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

